Humacyte, Inc. (HUMA) income statement
HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.50−0.00 (-0.20%)
Close on Nov 18, 2026Market cap $138.90MP/E –Yield –
Humacyte, Inc. financial ratios
See a number that looks wrong?